NationalTop Headlines

Moderna CEO expects emergency use nod for COVID-19 vaccine after FDA panel meet

The Food and Drug Administration is scheduled to hold the meeting on December 17 to discuss the company’s request for emergency use authorisation for its vaccine.

Moderna’s Covid-19 vaccine could be approved for emergency use within 24 to 72 hours after the US health regulator’s advisory committee meeting, Chief Executive Officer Stéphane Bancel said.

The Food and Drug Administration is scheduled to hold the meeting on December 17 to discuss the company’s request for emergency use authorisation for its vaccine.

Bancel said, Moderna currently has millions of doses of vaccines that can be shipped as soon as its request is granted.

Moderna, which is one of the front-runners in the race to develop a coronavirus vaccine, has applied for emergency authorisations both in the US and the EU after full results from a late-stage study showed its vaccine was 94.1% effective with no serious safety concerns.

Tags

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button